Identification of novel SNPs in SYK gene of breast cancer patients: Computational analysis of SNPs in the 5′UTR

Molecular Biology Reports

Volumn 39, Issue 8, 2012, Pages 8345-8351

  Kanwal, Sehrish ^a   Kayani, Mahmood Akhtar ^a   Faryal, Rani ^a  

^a Department of Electrical Computer Engineering   (Pakistan)

Author keywords

5 UTR; Breast cancer; Novel SNPs; SYK gene

Indexed keywords

GUANINE; PROTEIN KINASE SYK; THYMINE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

5' SPLICE DONOR SITE; 5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PATIENT; COMPUTER MODEL; CONTROLLED STUDY; ETHNIC GROUP; EXON; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC IDENTIFICATION; GENETIC VARIABILITY; GERM LINE; HUMAN; INTRON; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PAKISTANI; RNA STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SYK GENE; BIOLOGY; BREAST TUMOR; CHEMISTRY; CONFORMATION; GENETIC PREDISPOSITION; GENETICS; METHODOLOGY; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE;

5' UNTRANSLATED REGIONS; ADULT; BASE SEQUENCE; BREAST NEOPLASMS; COMPUTATIONAL BIOLOGY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; NUCLEIC ACID CONFORMATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-TYROSINE KINASES;

EID: 84868646487     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1684-y     Document Type: Article

References (38)

1. Lacey JV Jr, Kreimer AR, Buys SS, Marcus PM, Chang SC, Leitzmann MF, Hoover RN, Prorok PC, Berg CD, Hartge P, Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Project Team (2009) Breast cancer epidemiology according to recognized breast cancer risk factors in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial cohort. BMC Cancer 9:84-91
2. Czernin J, Benz MR, Allen-Auerbach MS (2011) Breast cancer. Methods Mol Biol 727:141-170
3. Malik IA (2002) Clinico-pathological features of breast cancer in Pakistan. J Pak Med Assoc 52:100-104
4. Naeem M, Khan N, Aman Z, Nasir A, Samad A, Khattak A (2008) Pattern of breast cancer: experience at lady reading hospital. Peshawar. J Ayub Med Coll Abbottabad 20(4):22-25
5. Osborne C, Wilson P, Tripathy D (2004) Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist 9(4):361-377
6. Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hannipman A, Michels AA, Staal GE (1992) Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res 52(17):4773-4778
7. Yuan Y, Mendez R, Sahin A, Dai JL (2001) Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 61(14):5558-5561
8. Elkak AE, Al-Sarakbi W, Mokbel K (2005) SYK expression in human breast cancer. J Carcino 4(1):7. (http://www.carcinogenesis.com/text.asp?2005/4/1/7/ 42212)
9. Lu X, Gu Y, Zhu D, Tan J, Liu X, Zha X (2009) Promoter methylation status of PTEN, SYK and surviving genes in breast cancer tissues derived from Chinese women. Asian Biomed 3(6):595-601
10. Zhang M, Huang J, Xie X, Holman CD (2009) Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int J Cancer 124(6):1404-1408
11. Moroni M, Soldatenkov V, Zhang L, Zhang Y, Stoica G, Gehan E, Rashidi B, Singh B, Ozdemirli M, Mueller SC (2004) Progressive loss of Syk and abnormal proliferation in breast cancer cells. Cancer Res 64(20):7346-7354
12. Zyss D, Montcourrier P, Vidal B, Anguille C, Mérezègue F, Sahuquet A, Mangeat PH, Coopman PJ (2005) The Syk tyrosine kinase localizes to the centrosomes and negatively affects mitotic progression. Cancer Res 65(23):10872-10880
13. Bailet O, Fenouille N, Abbe P, Robert G, Rocchi S, Gonthier N, Denoyelle C, Ticchioni M, Ortonne JP, Balloti R, Deckert M, Tartare-Deckert S (2009) Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest. Cancer Res 69(7):2748-2756
14. Coopman PJ, Do MT, Barth M, Bowden ET, Hayes AJ, Basyuk E, Blancato JK, Vezza PR, McLeskey SW, Mangeat PH, Mueller SC (2000) The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406(6797):742-747
15. Stewart ZA, Pietenpol JA (2001) Syk: a new player in the field of breast cancer. Breast Cancer Res 3(1):5-7
16. Yuan Y, Liu H, Sahin A, Dai JL (2005) Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness. Int J Cancer 113(4):654-659
17. Toyama T, Iwase H, Yamashita H, Hara Y, Omoto Y, Sugiura H, Zhang Z, Fujii Y (2003) Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett 189(1):97-102
18. Wang L, Duke L, Zhang PS, Arlinghaus RB, Symmans WF, Sahin A, Mendez R, Dai JL (2003) Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res 63(15):4724-4730
19. Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor, New York
20. http://mfold.rna.albany.edu/
21. Markham NR, Zuker M (2008) UNAFold: software for nucleic acid folding and hybridization. Methods Mol Biol 453:3-31
22. Boyle P, Levin B (2008) World cancer report 2008. International agency for research on cancer (World Health Organization), Lyon
23. Aftab ML, Rashid A (1998) A clinico pathological study of carcinoma breast. Pak J Health 35(3-4):96-98
24. Prehn A, Clarke C, Topol B, Glaser S, West D (2002) Increase in breast cancer incidence in middle-aged women during the 1990′s. Ann Epidemiol 12(7):476-481
25. Shaheen G, Arshad M, Shamim T, Shah, SMA, Ansari KA, Asif HM, Akram M, Mohiuddin E, Ayaz S (2010) Prevalence of breast cancer in punjab. The Internet Journal of Public Health 1(1). (http://www.ispub.com/journal/the-internet- journal-of-public-health/volume-1-number-1/prevalence-of-breast-cancer-in- punjab.html)
26. Nkondjock A, Ghadirian P (2004) Epidemiology of breast cancer among BRCA mutation carriers: an overview. Cancer Lett 205(1):1-8
27. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN (1995) Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87(22):1681-1685
28. Milne RL, Antoniou AC (2011) Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers. Ann Oncol 22(Suppl 1):i11-i17
29. Sada K, Takano T, Yanagi S, Yamamura H (2001) Structure and function of Syk protein-tyrosine kinase. J Biochem 130(2):177-186
30. McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases: breast cancer-epidemiology, risk factors, and genetics. BMJ 321(7261):624-628
31. Venables JP (2004) Aberrant and alternative splicing in cancer. Cancer Res 64(21):7647-7654
32. Brinkman BM (2004) Splice variants as cancer biomarkers. Clin Biochem 37(7):584-594
33. Guhaniyogi J, Brewer G (2001) Regulation of mRNA stability in mammalian cells. Gene 265(1-2):11-23
34. Pesole G, Grillo G, Larizza A, Liuni S (2000) The untranslated regions of eukaryotic mRNAs: structure, function, evolution and bioinformatic tools for their analysis. Brief Bioinform 1(3):223-249
35. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV (2003) Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12(3):205-216
36. Wang G, Guo X, Floros J (2005) Differences in the translation efficiency and mRNA stability mediated by 5′-UTR splice variants of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol 289(3):L497-L508
37. Signori E, Bagni C, Papa S, Primerano B, Rinaldi M, Amaldi F, Fazio VM (2001) A somatic mutation in the 5′UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency. Oncogene 20(33):4596-4600
38. Pesole G, Mignone F, Gissi C, Grillo G, Licciulli F, Liuni S (2001) Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276(1-2):73-81